AVXL
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Anavex provided an update on EU regulatory review of blarcamesine for early Alzheimer's diseaseMar 25, 2026
- Anavex Life Sciences receives FDA feedback on its Alzheimer's disease programJan 6, 2026
- Anavex submits EMA re-examination requestDec 18, 2025
- Anavex Life Sciences provided regulatory update on Blarcamesine for early Alzheimer's diseaseNov 14, 2025
- Anavex Life Sciences announces successful development of once-daily oral tablet formulation for the ANAVEX®3-71 programOct 2, 2025